Cargando…
Temozolomide in paediatric high-grade glioma: a key for combination therapy?
This report describes a single-centre study with temozolomide (TMZ) (200 mg m(−2) day(−1) × 5 per cycle of 28 days) in children with (recurrent) high-grade glioma. Magnetic resonance imaging was performed every two cycles. In all, 20 patients were treated between 1998 and 2001 after the UKCCSG/SFOP...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409857/ https://www.ncbi.nlm.nih.gov/pubmed/15266331 http://dx.doi.org/10.1038/sj.bjc.6601997 |